New York, United States, March 20, 2020 (GLOBE NEWSWIRE) -- The global recombinant cell culture supplements market, valued at US$ 320 Mn by the end of 2018, will grow at a steady rate from 2029-2029. The market players are investing in research and development activities to create new vaccines. They are targeting developing nations such as India and China for the same to benefit from their favorable government policies regarding foreign investments. Manufacturers are enhancing their presence across different distribution networks to market their products.
Recombinant Cell Culture Supplements Market: Key Takeaways
- Clinical growth factors will hold more than half of the market share owing to their escalated use in clinical studies.
- Recombinant insulin products will witness rapid growth in adoption through 2010-2029, for its widespread use in cell culture media.
- Stem cell therapy will generate major revenue in the market on the back of growth in the adoption of treatments and therapies related to stem cells.
- Microorganism-based recombinant cell culture supplements will gain rapid traction in the market from 2029-2029.
- North America will lead the market in terms of revenue on the back of rigorous developments in life sciences.
Request for sample Report: https://www.persistencemarketresearch.com/samples/31310
Recombinant Cell Culture Supplements Market: Key Growth Drivers
- Government-supported researches and clinical trials are boosting the adoption of recombinant cell culture supplements.
- Cost-effective R&D activities in developing economies encourage the use of recombinant cell culture supplements for various activities, creating opportunities for growth in the market.
- Animal-free recombinant cell culture supplements are gaining popularity in the market owing to the reduced risk of contamination.
- A high rate of researches in oncology is creating grounds for recombinant cell culture supplements to thrive, bolstering the market expansion.
Recombinant Cell Culture Supplements Market: Key Restraints
- The shortage of skilled professionals in the R& D segment utilizing recombinant cell culture supplements is a major challenge before the market.
- Lack of laboratory infrastructure to use recombinant cell culture supplements is hindering the smooth adoption of recombinant cell culture supplements in clinical studies.
The complete recombinant cell culture supplements market report with detailed market segmentation, 200 illustrative figures, and 63 data tables spread across 306 pages on https://www.persistencemarketresearch.com/methodology/31310
Recombinant Cell Culture Supplements Market: Competition Landscape
The competition landscape is highly intense where every player is expanding its product portfolio to stay at the forefront in the market. established players are acquiring regional players to strengthen their regional footprint. For instance, Thermo Fisher Scientific acquired the bio-processing business of Becton Dickinson to expand its product portfolio.
Get Persistence Market Research's Detailed Coverage On
Cell Culture Media Market: Get intensive information on the global cell culture media market with vital updates on market growth drivers, changing market dynamics, existing market challenges, government policies and laws, segmental market forecast and key market strategies prominent players.
Human Platelet Lysate Market: PMR's study on the global human platelet lysate market provides an exhaustive analysis of the market set for steady during 2019-2029. The study also elaborates on a detailed evaluation of key forces influencing growth in the market, major revenue strategies and key market players with their winning market strategies.
Autogenous Vaccines Market: Get vital information on the global autogenous vaccines market with segment-based analysis, major market statistics, and key growth factors, prominent market players and key marketing strategies adopted by them for a period under projection.
Gain access to Market Ngage, an AI-powered, real-time business intelligence platform that goes beyond the conventional research solutions to solve the complex strategy challenges that organizations face today.
About the Report
Persistence Market Research's market research study on the recombinant cell culture supplements market contains a global analysis of the market through 2014–2018 and provides growth assessment for 2019–2029. The study offers insightful details of the hydrogen market through four major segments – delivery mode, end-use, production method, and region.
About Persistence Market Research
Persistence Market Research (PMR) is an innovative and specialized supplier of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PMR. The company's research capabilities cover 5 continents, 1500+ reports, and 8 next-gen vertical expertise that have been catering to research demands of 5000+ clients.
Contact:
Rajendra Singh
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
For Sales Enquiries: sales@persistencemarketresearch.com
For Media Enquiries: media@persistencemarketresearch.com
Research Report: https://www.persistencemarketresearch.com/market-research/recombinant-cell-culture-supplements-market.asp
Press Release Source: https://www.persistencemarketresearch.com/mediarelease/recombinant-cell-culture-supplements-market.asp
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
